Case number 1:20-cv-01426
Novartis Pharmaceuticals Corporation v. Aurobindo Pharma Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 27, 2023 | 175 | Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 03/27/2023) (5) |
| Mar 15, 2023 | 174 | STIPULATION of Dismissal as to Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 03/15/2023) (2) |
| Mar 13, 2023 | 173 | NOTICE to Take Deposition of Paul Laskar, Ph.D. [AMENDED] on March 16, 2023 filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 03/13/2023) (2) |
| Mar 8, 2023 | 172 | NOTICE to Take Deposition of Paul Laskar, Ph.D. on March 16, 2023 filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 03/08/2023) (2) |
| Mar 6, 2023 | 171 | NOTICE OF SERVICE of Defendants' Reply Expert Report of Paul A. Laskar, Ph.D. on Patent Invalidity filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 03/06/2023) (3) |
| Mar 3, 2023 | 170 | NOTICE OF SERVICE of (1) Aurobindo's Reply Expert Report of Pat Confalone regarding Invalidity; and (2) Aurobindo's Reply Expert Report of Ivan Hofmann filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) (Entered: 03/03/2023) (2) |
| Feb 10, 2023 | 169 | STIPULATION TO EXTEND TIME See Stip for Details to - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 02/10/2023) (3) |
| Feb 8, 2023 | 168 | ORAL ORDER: Having reviewed the parties' Stipulation and [Proposed Order] to Extend Time (D.I. 167), the requested extensions do not leave sufficient time for the Court to review, evaluate and issue opinions on Daubert motion(s) before the Pretrial Conference and Trial currently scheduled for June 5, 2023 and June 12, 2023 respectively. If Court grants the requested extensions, the Court will need to reschedule the Pretrial Conference and Trial to later available dates in 2023 or 2024. Alternatively, the Court can accommodate an extension to the Daubert motion deadline to April 17, 2023. Therefore, IT IS HEREBY ORDERED THAT, on or before Friday, February 10, 2023, the parties should advise the Court whether they still want the requested extension of deadlines or otherwise file a revised stipulation extending the deadline for Daubert motions to April 17, 2023 and adjusting other deadlines accordingly. ORDERED by Judge Gregory B. Williams on 2/8/23. Associated Cases: 1:20-cv-01426-GBW, 1:21-cv-01656-GBW (ntl) (Entered: 02/08/2023) (0) |
| Feb 6, 2023 | 167 | STIPULATION TO EXTEND TIME (1) Reply Expert Reports, (2) Close of Expert Discovery, and (3) Deadline for Daubert Motions to (1) March 3, 2023, (2) April 17, 2023, and (3) April 24, 2023 - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 02/06/2023) (2) |
| Jan 23, 2023 | 166 | NOTICE OF SERVICE of (1) Responsive Expert Report of Dr. Steven Boyd; (2) Responsive Expert Report of Dr. Christopher Vellturo; (3) Responsive Expert Report of Dr. Steven Little; (4) Responsive Expert Report of Dr. Alan Myerson; and (5) Responsive Expert Report of Dr. Stephen Pflugfelder, and supporting documents filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 01/23/2023) (3) |
| Jan 18, 2023 | 165 | STIPULATION of Dismissal by Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 01/18/2023) (2) |
| Jan 10, 2023 | 164 | STIPULATION TO EXTEND TIME See Stip for Details to - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 01/10/2023) (2) |
| Dec 6, 2022 | 163 | SCHEDULING ORDER (See Order for further details). Signed by Judge Gregory B. Williams on 12/6/22. Associated Cases: 1:20-cv-01426-GBW, 1:21-cv-01656-GBW (ntl) (Entered: 12/06/2022) (13) |
| Nov 10, 2022 | 162 | PROPOSED ORDER Scheduling (ANDA) by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 11/10/2022) (13) |
| Nov 7, 2022 | 159 | NOTICE OF SERVICE of Defendants Aurobindo, Micro labs and Sun's Opening Expert Report of Robert Cykiert, M.D. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) (Entered: 11/07/2022) (2) |
| Nov 7, 2022 | 160 | NOTICE OF SERVICE of Expert Report of Pat N. Confalone, Ph.D. Regarding Invalidity of U.S. Patent Nos. 7,314,938; 7,790,743; 8,168,655; 8,084,047; 8,592,450; 8,367,701; and 9,447,077 filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) (Entered: 11/07/2022) (2) |
| Nov 7, 2022 | 161 | NOTICE OF SERVICE of Defendants' Opening Expert Report of Paul A. Laskar, Ph.D. on Patent Invalidity filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 11/07/2022) (3) |
| Nov 1, 2022 | 158 | Letter to The Honorable Gregory B. Williams from Daniel M. Silver, Esq.. (Silver, Daniel) (Entered: 11/01/2022) (1) |
| Oct 28, 2022 | 156 | ORAL ORDER: IT IS HEREBY ORDERED that, not later than fourteen (14) days from the date of this Order, the parties shall meet and confer and file a joint amended proposed Scheduling Order in this action consistent with the applicable form Scheduling Order of Judge Williams, which is posted at http://www/ded/uscourts.gov (See Chambers, Judge Williams, Forms), along with a cover letter requesting the Court to enter the joint amended proposed Scheduling Order (if there are no disputes or other issues concerning scheduling in the joint amended proposed Scheduling Order that the Court needs to address) or to schedule a status conference. If there are disputes or other issues the Court needs to address in the joint amended proposed Scheduling Order, in the cover letter, the parties shall direct the Court to the paragraph numbers in the joint amended proposed Scheduling Order which those appear. Except for good cause shown, the parties shall not change any of the dates included in the existing scheduling order in this action. ORDERED by Judge Gregory B. Williams on 10/28/22. (ntl) (Entered: 10/28/2022) (0) |
| Oct 28, 2022 | 157 | NOTICE OF SERVICE of Plaintiff's Final Validity Contentions Regarding U.S. Patent No. 7,314,938; U.S. Patent No. 7,790,743; U.S. Patent No. 8,168,655; U.S. Patent No. 8,084,047; U.S. Patent No. 8,592,450; U.S. Patent No. 8,367,701; U.S. Patent No. 9,447,077; and U.S. Patent No. 11,058,677 filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 10/28/2022) (4) |
| Oct 26, 2022 | 155 | NOTICE of Appearance by Carl Douglas Neff on behalf of Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Neff, Carl) (Entered: 10/26/2022) (1) |
| Oct 18, 2022 | 154 | STIPULATION TO EXTEND TIME See Stip for Details to - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 10/18/2022) (3) |
| Oct 7, 2022 | 153 | Joint STIPULATION and [Proposed] Order Regarding Case Narrowing re 149 Stipulation by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 10/07/2022) (2) |
| Sep 23, 2022 | 150 | STIPULATION and [Proposed] Order by Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 09/23/2022) (4) |
| Sep 23, 2022 | 151 | NOTICE OF SERVICE of Plaintiff's Final Infringement Contentions to Defendants Micro Labs USA Inc. and Micro Labs Limited filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) (Entered: 09/23/2022) (2) |
| Sep 23, 2022 | 152 | NOTICE OF SERVICE of Defendants' Joint Final Invalidity Contentions Regarding U.S. Patent No. 7,314,938; U.S. Patent No. 7,790,743; U.S. Patent No. 8,168,655; U.S. Patent No. 8,084,047; U.S. Patent No. 8,592,450; U.S. Patent No. 8,367,701; U.S. Patent No. 9,447,077; and U.S. Patent No. 11,058,677 filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) (Entered: 09/23/2022) (2) |
| Sep 14, 2022 | 149 | STIPULATION and [Proposed] Order by Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 09/14/2022) (5) |
| Sep 12, 2022 | 148 | NOTICE to Take Deposition of Dr. Min Zhong on September 18, 2022 filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) (Entered: 09/12/2022) (4) |
| Sep 9, 2022 | 147 | NOTICE to Take Deposition of Dr. Tom Gadek (Amended) on September 14, 2022 filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) (Entered: 09/09/2022) (4) |
| Sep 8, 2022 | 146 | STIPULATION and [Proposed] Order by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) (Entered: 09/08/2022) (3) |
| Sep 6, 2022 | 145 | NOTICE to Take Deposition of Mary Newman on September 8, 2022 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 09/06/2022) (4) |
| Sep 1, 2022 | 143 | STIPULATION TO EXTEND TIME Joint Letter Regarding Any Additional Claim Construction Issues to October 18, 2022 - filed by Micro Labs Limited, Micro Labs USA Inc.. (Haney, Megan) (Entered: 09/01/2022) (3) |
| Sep 1, 2022 | 144 | SO ORDERED re (143 in 1:20-cv-01426-MN, 73 in 1:21-cv-01656-MN) STIPULATION TO EXTEND TIME to file Joint Letter Regarding Any Additional Claim Construction Issues to October 18, 2022 for the Micro Labs and Aurobindo Defendants. Signed by Judge Maryellen Noreika on 9/1/2022. (dlw) (Entered: 09/01/2022) (3) |
| Aug 24, 2022 | 142 | NOTICE requesting Clerk to remove Steven J. Moore, James E. Nealon, Lina Genovesi and Withers Bergman LLP as co-counsel.. (Dorsney, Kenneth) (Entered: 08/24/2022) (1) |
| Aug 23, 2022 | 140 | MOTION for Pro Hac Vice Appearance of Attorney Gongjun ("Gary" ) Ji and Attorney Gurpreet Singh ("Ray") Walia - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) (Entered: 08/23/2022) (4) |
| Aug 23, 2022 | 141 | NOTICE to Take Deposition of Christopher M. Adams on August 24, 2022 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 08/23/2022) (4) |
| Aug 15, 2022 | 138 | NOTICE to Take Deposition of Wilmette Dadzie on August 19, 2022 filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Hitch, Cortlan) (Entered: 08/15/2022) (4) |
| Aug 15, 2022 | 139 | NOTICE to Take Deposition of Robert Gleeson on August 19, 2022 filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Hitch, Cortlan) (Entered: 08/15/2022) (4) |
| Aug 9, 2022 | 137 | ANSWER to 136 Answer to Amended Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 08/09/2022) (30) |
| Jul 29, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 137 has been deleted from the docket at the request of counsel. (dlw) |
| Jul 28, 2022 | 136 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [37] Amended Complaint , COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Micro Labs USA Inc., Micro Labs Limited.(Haney, Megan) |
| Jul 27, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (132 in 1:20-cv-01426-MN, 61 in 1:21-cv-01656-MN) Stipulation and Proposed Order - WHEREAS, the parties have submitted a proposed stipulation that includes, inter alia, new pre-trial deadlines that extend Daubert briefing but keep the existing pretrial conference and trial dates; WHEREAS, should this case proceed to trial, it will be a bench trial (see D.I. 93 in C.A. No. 20-1426 and D.I. 18 in C.A. No. 21-1656); WHEREAS, "[w]hen the role of the gatekeeper to admit or exclude evidence (the judge) and the role of the factfinder to assess and weigh the evidence... (the jury) are one and the same, the judge who becomes the factfinder as well as the gatekeeper... should not be required to waste judicial time" In re Unisys, 173 F.3d 145, 155-58 (3d Cir. 1999); and WHEREAS, the Court can better address Daubert issues in context at trial when the Court can hear testimony and better understand the bases for the experts' opinions. THEREFORE, IT IS HEREBY ORDERED that, should any party wish to file Daubert motions, they shall file a letter seeking permission to do so. Opening letter briefs shall be no longer than three (3) pages and shall be filed with the Court on or before 3/31/2023. Answering letter briefs shall be no longer than three (3) pages and shall be filed with the Court no later than seven (7) days after the filing of the opening letter briefs. No replies shall be filed. Unless the Court grants leave for additional letters to be filed, each side shall present all grounds on which it seeks permission to file Daubert motions in its single opening letter brief. IT IS FURTHER ORDERED that the parties shall submit an updated stipulation including the above provisions for the Court's consideration. ORDERED by Judge Maryellen Noreika on 7/27/2022. (dlw) |
| Jul 27, 2022 | 134 | Main Document (3) Docket Text: STIPULATION and [Proposed] Order by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A)(Joyce, Alexandra) |
| Jul 27, 2022 | 134 | Exhibit A (2) |
| Jul 27, 2022 | 135 | SO ORDERED (5) Docket Text: SO ORDERED re (63 in 1:21-cv-01656-MN, 134 in 1:20-cv-01426-MN) Stipulation and Order (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 9/14/2022. Opening Expert Reports due by 10/24/2022. Rebuttal Expert Reports due by 12/22/2022. Reply Expert Report due by 1/20/2023. Expert Discovery due by 3/24/2023). SEE STIPULATION FOR FURTHER AND COMPLETE DETAILS. Signed by Judge Maryellen Noreika on 7/27/2022. (dlw) |
| Jul 26, 2022 | 132 | Main Document (3) Docket Text: STIPULATION and [Proposed] Order by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A)(Joyce, Alexandra) |
| Jul 26, 2022 | 132 | Exhibit A (1) |
| Jul 22, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [130] STIPULATION TO EXTEND TIME for Micro Labs to answer, move or otherwise respond to the Amended Complaint (D.I. 126) to July 28, 2022 (Set/Reset Answer Deadlines: Micro Labs Limited answer due 7/28/2022; Micro Labs USA Inc. answer due 7/28/2022). ORDERED by Judge Maryellen Noreika on 7/22/2022. (dlw) |
| Jul 22, 2022 | 131 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendants Amended First Common Interrogatories (Nos. 1-3) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jul 21, 2022 | 130 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Micro Labs to answer, move or otherwise respond to the Amended Complaint (D.I. 126) to July 28, 2022 - filed by Micro Labs Limited, Micro Labs USA Inc.. (Haney, Megan) |
| Jul 15, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (57 in 1:21-cv-01656-MN, 128 in 1:20-cv-01426-MN) STIPULATION TO EXTEND TIME for the Close of Fact Discovery to July 20, 2022 filed by Novartis Pharmaceuticals Corporation, Set/Reset Scheduling Order Deadlines: ( Fact Discovery completed by 7/20/2022). ORDERED by Judge Maryellen Noreika on 7/15/2022. Associated Cases: 1:20-cv-01426-MN, 1:21-cv-01656-MN(mdb) |
| Jul 15, 2022 | 128 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the Close of Fact Discovery to July 20, 2022 - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Jul 15, 2022 | 129 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendants' Amended First Set of Requests for Production (Nos. 1-96) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jul 7, 2022 | 124 | Main Document (2) Docket Text: STIPULATION and [Proposed] Order Regarding First Amended Complaint Against Micro Labs Limited and Micro Labs USA, Inc. by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A - First Amended Complaint Against Micro Labs, # (2) Exhibit B - Redline of First Amended Complaint)(Silver, Daniel) |
| Jul 7, 2022 | 124 | Exhibit A - First Amended Complaint Against Micro Labs (70) |
| Jul 7, 2022 | 124 | Exhibit B - Redline of First Amended Complaint (78) |
| Jul 7, 2022 | 125 | SO ORDERED (2) Docket Text: SO ORDERED re [124] Stipulation and Order Regarding First Amended Complaint Against Micro Labs USA, Inc. Signed by Judge Maryellen Noreika on 7/7/2022. (dlw) |
| Jul 7, 2022 | 126 | Main Document (69) Docket Text: AMENDED COMPLAINT against Micro Labs Limited and Micro Labs USA, Inc. - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibits A-D, # (2) Exhibits E-I, # (3) Exhibits J-L, # (4) Exhibits M-P)(Silver, Daniel) Modified on 7/8/2022 (dlw). |
| Jul 7, 2022 | 126 | Exhibits A-D (360) |
| Jul 7, 2022 | 126 | Exhibits E-I (337) |
| Jul 7, 2022 | 126 | Exhibits J-L (315) |
| Jul 7, 2022 | 126 | Exhibits M-P (263) |
| Jul 7, 2022 | 127 | Patent/Trademark Report to Commissioner (1) Docket Text: Additional Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,058,677. (Silver, Daniel) Modified on 7/8/2022 (dlw). |
| Jul 7, 2022 | 126 | Amended Complaint* (1) |
| Jul 6, 2022 | 123 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Mary Newman on July 15, 2022 filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Hitch, Cortlan) |
| Jun 27, 2022 | 122 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Micro Labs Limited and Micro Labs USA Inc.'s Objections and Responses to Plaintiff's Notice of Deposition of Defendants Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) |
| Jun 21, 2022 | 101 | Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Christopher M. Adams filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 102 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Kenneth Barr filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 103 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of John Burnier filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 104 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Thomas Gadek filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 105 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of William Hunke filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 106 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Wang Shen filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 107 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of James Robert Zeller filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 108 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Mark Bridle filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 21, 2022 | 109 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Adarsh Jain filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 110 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Harnam Singh filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 111 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of T. Jagdeeswar Rao filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 112 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Karunakaran Gandam filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 113 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Muthukumaran N filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 114 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. Neela Praveen Kumar filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 115 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Pramod Kumar filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 116 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. Praveen Varma filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 117 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Sureka Khopade filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 118 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Surekha Kopade filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 119 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Sujeet Shrivastava filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 120 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Vinita Chandrawanshi filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 21, 2022 | 121 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff Novartis Pharmaceuticals Corporation's Amended Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 15, 2022 | 99 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendants' Notice of Deposition of Plaintiff Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 15, 2022 | 100 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Aurobindo, Micro Labs, and Sun's Amended First Set of Joint Requests for Production to Plaintiffs (Nos. 1-96) and; (2) Defendants Aurobindo, Micro Labs, and Sun's Amended First Set of Interrogatories to Plaintiffs (Nos. 1-3) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 13, 2022 | 98 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Notice of 30(b)(6) Deposition of Defendants filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jun 3, 2022 | 97 | Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Plaintiff Novartis Pharmaceuticals Corporation Pursuant to Fed. R. Civ. P. 30(b)(6) on June 23, 2022 filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) |
| Apr 29, 2022 | 96 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Alexandra M. Joyce (Joyce, Alexandra) |
| Apr 28, 2022 | 95 | SO ORDERED (3) Docket Text: SO ORDERED re (21 in 1:21-cv-01656-MN, 94 in 1:20-cv-01426-MN) Stipulation and Order Regarding the Protective Order. Signed by Judge Maryellen Noreika on 4/28/2022. (dlw) |
| Apr 27, 2022 | 94 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding the Protective Order by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Apr 19, 2022 | 93 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Fact Discovery completed by 7/15/2022. Opening Expert Reports due by 9/9/2022. Rebuttal Expert Reports due by 11/8/2022. Reply Expert Reports due by 12/9/2022. Expert Discovery due by 3/10/2023. A Pretrial Conference is set for 6/5/2023 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 6/12/2023 at 08:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 4/19/2022. (dlw) |
| Apr 14, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Burke for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (dlb) |
| Apr 14, 2022 | 92 | Proposed Order (11) Docket Text: PROPOSED ORDER // Scheduling Order by Micro Labs USA Inc. (Haney, Megan) Modified on 4/18/2022 (dlw). |
| Apr 11, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re (91 in 1:20-cv-01426-MN, 16 in 1:21-cv-01656-MN) STIPULATION TO EXTEND TIME to Submit Proposed Revised Scheduling Order to April 14, 2022. ORDERED by Judge Maryellen Noreika on 4/11/2022. (dlw) |
| Apr 8, 2022 | 91 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Revised Scheduling Order to April 14, 2022 - filed by Micro Labs Limited, Micro Labs USA Inc.. (Phillips, John) |
| Apr 4, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (88 in 1:20-cv-01426-MN, 14 in 1:21-cv-01656-MN) STIPULATION TO EXTEND TIME to submit a revised scheduling order to April 8, 2022 filed by Micro Labs USA Inc., Micro Labs Limited. ORDERED by Judge Maryellen Noreika on 4/4/2022. Associated Cases: 1:20-cv-01426-MN, 1:21-cv-01656-MN(mdb) |
| Apr 1, 2022 | 88 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a revised scheduling order to April 8, 2022 - filed by Micro Labs Limited, Micro Labs USA Inc.. (Phillips, John) |
| Apr 1, 2022 | 89 | Letter (1) Docket Text: Letter to The Honorable Maryellen Noreika from Daniel M. Silver, Esq. regarding Joint Status Report. (Silver, Daniel) |
| Apr 1, 2022 | 90 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Objections and Responses to Defendant Micro Labs' First Set of Individual Interrogatories (No. 1) and (2) Plaintiff's Objections and Responses to Defendants' First Set of Common Interrogatories (Nos. 1-3) filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Mar 25, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [87] STIPULATION TO EXTEND the Deadline to Submit a Revised Scheduling Order to April 4, 2022 (from March 28, 2022). ORDERED by Judge Maryellen Noreika on 3/25/2022. (dlw) |
| Mar 25, 2022 | 87 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME the Deadline to Submit a Revised Scheduling Order to April 4, 2022 (from March 28, 2022) - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Mar 22, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 85 (NOTICE OF SERVICE of Aurobindo's Final Invalidity Contentions) has been deleted from the docket at the request of counsel and D.I. 86 (NOTICE OF SERVICE of Aurobindo and Micro Labs' Joint Final Invalidity Contentions) has been renumbered as D.I. 85. (dlw) |
| Mar 22, 2022 | 86 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo and Micro Labs' Corrected Final Invalidity Contentions filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Mar 21, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that, on or before 3/28/2022, the parties' shall conform the Scheduling Order in this case to this Court's form order. The bench trial will begin on 6/12/2023 and will be set for 5 days with the actual number of trial days determined closer to trial. The pretrial conference will be held on 6/5/2023 at 4:30 PM in Courtroom 4A. IT IS FURTHER ORDERED that, if not already complete, the parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes. Once complete, the parties shall submit a joint letter confirming that the final contentions have not raised any additional claim construction issues. ORDERED by Judge Maryellen Noreika on 3/21/2022. (dlw) |
| Mar 21, 2022 | 85 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo and Micro Labs' Joint Final Invalidity Contentions filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) Modified on 3/22/2022 (dlw). |
| Mar 11, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:20-cv-01426-MN, 1:21-cv-00969-MN, 1:21-cv-01656-MN (rjb) |
| Mar 7, 2022 | 83 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Final Infringement Contentions to Defendants filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Feb 24, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [82] STIPULATION and Proposed Order to Extend Time by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 2/24/2022. (etg) |
| Feb 22, 2022 | 82 | Stipulation (2) Docket Text: STIPULATION and Proposed Order to Extend Time by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Feb 17, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kathryn E. Garza for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Feb 16, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [80] MOTION for Pro Hac Vice Appearance of Attorney Kathryn E. Garza filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 2/16/22. (ntl) |
| Feb 15, 2022 | 80 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kathryn E. Garza - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Certification for Kathryn E. Garza)(Silver, Daniel) |
| Feb 15, 2022 | 80 | Certification for Kathryn E. Garza (1) |
| Feb 15, 2022 | 81 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' First Joint of Interrogatories to Plaintiff (Nos. 1-3) and (2) Micro Labs' First Individual Set of Interrogatories (No. 1) filed by Micro Labs Limited.(Haney, Megan) |
| Feb 7, 2022 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Markman Hearing (by Telephone Conference) held on 2/7/2022. (Court Reporter M. Rolfe.) (ntl) |
| Feb 7, 2022 | 79 | Order (1) Docket Text: ORDER regarding claim construction. Signed by Judge Leonard P. Stark on 2/7/22. (ntl) |
| Feb 3, 2022 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Markman hearing on February 7, 2022 will begin at 3:00 p.m. and will be held remotely via teleconference to be arranged by counsel. The hearing must be available for public access. The parties shall submit electronic versions of any slides or other demonstrative materials they may refer to by no later than 3:00 p.m. the day before the hearing. ORDERED by Judge Leonard P. Stark on 2/3/22. (ntl) |
| Feb 3, 2022 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the teleconference hearing scheduled for February 7, 2022 at 3:00 p.m. is available to the public using the following dial-in for access: (866) 232-4418 Code: 7451902378. One touch mobile dial-in: 8662324418,,7451902378# Audio reproduction of the proceeding is strictly prohibited. ORDERED by Judge Leonard P. Stark on 2/3/22. (ntl) |
| Jan 24, 2022 | 75 | Redacted Document (30) Docket Text: REDACTED VERSION of [73] Joint Claim Construction Brief by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Jan 24, 2022 | 76 | Redacted Document (30) Docket Text: REDACTED VERSION of [74] Appendix, by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Jan 12, 2022 | 72 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Reply Claim Construction Brief filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Dec 27, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [71] MOTION for Pro Hac Vice Appearance of Attorney Lina Genovesi filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 12/27/21. (ntl) |
| Dec 23, 2021 | 70 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendants' First Set of Requests for Production (Nos. 1-96) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Dec 23, 2021 | 71 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lina Genovesi - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Dec 14, 2021 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Markman Hearing on February 7, 2022 will begin at 4:30 p.m. and each side will be allocated up to twenty (20) minutes for argument. ORDERED by Judge Leonard P. Stark on 12/14/21. (ntl) |
| Dec 10, 2021 | 68 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Kevin Burgess, Ph.D. on December 20, 2021 at 9:00 a.m. ET filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Dec 9, 2021 | 66 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Micro Labs and Aurobindo's Joint Responsive Claim Construction Brief filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Dec 9, 2021 | 67 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Daniel M. Silver, Esq. regarding Claim Construction Hearing. (Silver, Daniel) |
| Dec 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [64] STIPULATION and [Proposed] Order to Extend Time Regarding Certain Claim Construction Deadlines filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 12/7/21. (ntl) |
| Dec 7, 2021 | 65 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Micro Labs Limited and Micro Labs USA, Inc.'s Initial Invalidity Contentions Pursuant to the Default Standard for Discovery filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) |
| Dec 6, 2021 | 64 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Extend Time Regarding Certain Claim Construction Deadlines by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Dec 2, 2021 | 63 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Aurobindo's response to Plaintiff's First Set of Interrogatories (Nos. 1-4); and (2) Aurobindo's response to Plaintiff's First Set of Requests for Admission (Nos. 1-11) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Nov 29, 2021 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Joint Requests for Production of Documents and Things (Nos. 1-96) filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) |
| Nov 29, 2021 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Micro Labs Limited's and Micro Labs USA, Inc.'s Objections and Responses to Plaintiff's First Set of Interrogatories and Defendants Micro Labs Limited's and Micro Labs USA, Inc.'s Objections and Reponses to Plaintiff's First Set of Requests for Admissions filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) |
| Nov 29, 2021 | 62 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Eric Anslyn on December 1, 2021 filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) |
| Nov 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [59] MOTION for Pro Hac Vice Appearance of Attorney Ian Scott filed by Micro Labs USA Inc., Micro Labs Limited. Signed by Judge Leonard P. Stark on 11/19/21. (ntl) |
| Nov 19, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ian Scott for Micro Labs Limited, for Micro Labs USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Nov 19, 2021 | 59 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ian Scott - filed by Micro Labs Limited, Micro Labs USA Inc.. (Attachments: # (1) Certification of Ian Scott)(Haney, Megan) |
| Nov 19, 2021 | 59 | Certification of Ian Scott (1) |
| Nov 18, 2021 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Micro Labs Limited's and Micro Labs USA, Inc.'s Objections and Responses to Plaintiff Novartis Pharmaceuticals Corporation's First Set of Requests for Production (Nos. 1-58) filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) |
| Nov 8, 2021 | 57 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and (2) Plaintiff Novartis Pharmaceuticals Corporation's Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Nov 5, 2021 | 56 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Opening Claim Construction Brief and Supporting Exhibits filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Oct 29, 2021 | 55 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Claim Charts to Defendants Micro Labs Limited and Micro Labs USA, Inc. filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Oct 26, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [52] STIPULATION and [Proposed] Order Regarding Forgoing Technology Tutorials filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 10/26/21. (ntl) |
| Oct 26, 2021 | 54 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests for Admission to Defendants (Nos. 1-11) and (2) Plaintiffs First Set of Interrogatories (Nos. 1-4) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Oct 25, 2021 | 52 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Forgoing Technology Tutorials by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Oct 25, 2021 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Micro Labs Limited and Mirco Labs USA Inc.'s 26(a)(1) Initial Disclosures and Defendant Micro Labs Limited's and Micro Labs USA Inc.'s Initial Disclosures Pursuant to the Delaware Default Standard for Discovery filed by Micro Labs Limited, Micro Labs USA Inc..(Haney, Megan) |
| Oct 20, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [48] STIPULATION TO EXTEND the Deadline to Submit the Joint Claim Construction Chart to October 20, 2021 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 10/20/21. (ntl) |
| Oct 20, 2021 | 50 | Claim Construction Chart (5) Docket Text: CLAIM Construction Chart by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Oct 20, 2021 | 51 | Main Document (3) Docket Text: Joint APPENDIX re [50] Claim Construction Chart by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit 1-14)(Silver, Daniel) |
| Oct 20, 2021 | 51 | Exhibit 1-14 (414) |
| Oct 19, 2021 | 49 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's First Set of Requests for Production to Defendants Micro Labs Limited and Micro Labs USA, Inc. (Nos. 1-58) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Oct 18, 2021 | 48 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME the Deadline to Submit the Joint Claim Construction Chart to October 20, 2021 - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Oct 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (46 in 1:20-cv-01426-LPS, 23 in 1:21-cv-00969-LPS) STIPULATION and Proposed Order Regarding Consolidation filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 10/13/21. Associated Cases: 1:20-cv-01426-LPS, 1:21-cv-00969-LPS (ntl) |
| Oct 11, 2021 | 47 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Preliminary Claim Constructions and Supporting Intrinsic Evidence filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Oct 7, 2021 | 46 | Stipulation (6) Docket Text: STIPULATION and Proposed Order Regarding Consolidation by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Sep 24, 2021 | 43 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Preliminary Claim Terms and Proposed Constructions filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Sep 24, 2021 | 44 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Identification of Claim Terms Identifying No Claim Terms for Construction filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Sep 24, 2021 | 45 | Answer to Counterclaim (13) Docket Text: ANSWER to [41] Answer to Amended Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Sep 23, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (21 in 1:21-cv-00969-LPS, 42 in 1:20-cv-01426-LPS) Stipulated Protective Order. Signed by Judge Leonard P. Stark on 9/23/21. Associated Cases: 1:20-cv-01426-LPS, 1:21-cv-00969-LPS (ntl) |
| Sep 21, 2021 | 42 | Proposed Order (30) Docket Text: PROPOSED ORDER Stipulated Protective Order by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Sep 16, 2021 | 41 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [37] Amended Complaint , COUNTERCLAIM against All Plaintiffs by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Sep 9, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [39] STIPULATION TO EXTEND TIME the Deadline to Submit a Proposed Protective Order to September 21, 2021 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 9/9/21. (ntl) |
| Sep 9, 2021 | 40 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Initial Invalidity Contentions filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Hitch, Cortlan) |
| Sep 8, 2021 | 39 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME the Deadline to Submit a Proposed Protective Order to September 21, 2021 - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Sep 7, 2021 | 37 | Main Document (70) Docket Text: First AMENDED COMPLAINT against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.- filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-D, # (2) Exhibit E-I, # (3) Exhibit J-L, # (4) Exhibit M-P)(Silver, Daniel) |
| Sep 7, 2021 | 37 | Exhibit A-D (360) |
| Sep 7, 2021 | 37 | Exhibit E-I (337) |
| Sep 7, 2021 | 37 | Exhibit J-L (315) |
| Sep 7, 2021 | 37 | Exhibit M-P (263) |
| Sep 7, 2021 | 38 | Patent/Trademark Report to Commissioner (3) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,314,938 ;7,745,460 ;7,745,743 ;7,928,122 ;9,216,174 ;10,124,000 ;8,084,047; 8,592,450; 8,168,655; 8,367,701; 9,447,077; 8,927,574; 9,353,088; 9,890,141; 9,085,553; 11,058,677 . (Silver, Daniel) |
| Sep 7, 2021 | 37 | Amended Complaint* (1) |
| Sep 3, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [36] STIPULATION and [Proposed] Order Regarding Plaintiff Novartis Pharmaceuticals Corporation's First Amended Complaint filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 9/3/21. (ntl) |
| Sep 2, 2021 | 36 | Main Document (3) Docket Text: STIPULATION and [Proposed] Order Regarding Plaintiff Novartis Pharmaceuticals Corporation's First Amended Complaint by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Joyce, Alexandra) |
| Sep 2, 2021 | 36 | Exhibit A (71) |
| Sep 2, 2021 | 36 | Exhibit B (74) |
| Sep 1, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [35] STIPULATION TO EXTEND TIME for Filing of Proposed Protective Order to September 8, 2021 filed by Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 9/1/21. (ntl) |
| Aug 31, 2021 | 35 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME Filing of Proposed Protective Order to September 8, 2021 - filed by Aurobindo Pharma Ltd.. (Hitch, Cortlan) |
| Aug 27, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [33] STIPULATION TO EXTEND TIME to submit the Proposed Protective Order to August 31, 2021 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd.; [34] Stipulation and Order Regarding Extending Deadlines filed by Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 8/27/21. (ntl) |
| Aug 26, 2021 | 34 | Stipulation (2) Docket Text: STIPULATION Amend Case Schedule by Aurobindo Pharma Ltd.. (Hitch, Cortlan) |
| Aug 20, 2021 | 33 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit the Proposed Protective Order to August 31, 2021 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Hitch, Cortlan) |
| Aug 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [32] STIPULATION TO EXTEND TIME for the parties to file the Proposed Protective Order to August 20, 2021 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 8/13/21. (ntl) |
| Aug 13, 2021 | 32 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to file the Proposed Protective Order to August 20, 2021 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Hitch, Cortlan) |
| Aug 12, 2021 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's responses to Plaintiff's First Set of Requests for Production (Nos. 1-58) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Aug 3, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [30] STIPULATION TO EXTEND TIME the Parties' Deadline to Submit a Proposed Protective Order to August 13, 2021 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 8/3/21. (ntl) |
| Jul 30, 2021 | 30 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME the Parties' Deadline to Submit a Proposed Protective Order to August 13, 2021 - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Jul 22, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [28] STIPULATION TO EXTEND TIME the Parties' Deadline to Submit a Proposed Protective Order to July 30, 2021 filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 7/22/21. (ntl) |
| Jul 22, 2021 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Claim Charts filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jul 16, 2021 | 28 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME the Parties' Deadline to Submit a Proposed Protective Order to July 30, 2021 - filed by Novartis Pharmaceuticals Corporation. (Joyce, Alexandra) |
| Jul 14, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney James E. Nealon for Aurobindo Pharma Ltd., and for Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (smg) |
| Jul 6, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [25] STIPULATION to Amend the Scheduling Order by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. Signed by Judge Leonard P. Stark on 7/6/2021. (etg) |
| Jul 6, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [26] STIPULATION TO EXTEND TIME to submit the Proposed Protective Order to July 16, 2021 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd.. Signed by Judge Leonard P. Stark on 7/6/2021. (etg) Modified on 7/7/2021 to reflect correct deadline (etg). |
| Jul 6, 2021 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's First Set of Requests for Production to Defendants (Nos. 1-58) filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra) |
| Jul 2, 2021 | 26 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit the Proposed Protective Order to July 16, 2021 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Dorsney, Kenneth) (Main Document 26 replaced on 7/5/2021) (ntl). Modified on 7/5/2021 (ntl). |
| Jul 1, 2021 | 25 | Stipulation (2) Docket Text: STIPULATION to Amend the Scheduling Order by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Jun 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [24] STIPULATION TO EXTEND TIME for the parties to file the Proposed Protective Order to July 2, 2021 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 6/29/21. (ntl) |
| Jun 25, 2021 | 24 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to file the Proposed Protective Order to July 2, 2021 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Hitch, Cortlan) |
| Jun 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [21] STIPULATION TO EXTEND TIME submit proposed protective order to June 18, 2021 filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 6/21/21. (ntl) |
| Jun 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [23] STIPULATION TO EXTEND TIME Filing of Proposed Protective Order to June 25, 2021 filed by Aurobindo Pharma USA, Inc. Signed by Judge Leonard P. Stark on 6/21/21. (ntl) |
| Jun 18, 2021 | 23 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME Filing of Proposed Protective Order to June 25, 2021 - filed by Aurobindo Pharma USA, Inc.. (Hitch, Cortlan) |
| Jun 14, 2021 | 21 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME submit proposed protective order to June 18, 2021 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Jun 14, 2021 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and (2) Plaintiff Novartis Pharmaceuticals Corporation's Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Jun 11, 2021 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Core technical documents filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Jun 4, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel) |
| Jun 4, 2021 | 18 | Scheduling Order (14) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 7/1/2022. Status Report due by 4/1/2022. Joint Claim Construction Brief due by 1/5/2022. A Markman Hearing is set for 2/7/2022 at 01:00 PM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 5/30/2023. A Final Pretrial Conference is set for 6/9/2023 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 7-day Bench Trial is set for 6/19/2023 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 6/3/21. (ntl) |
| Jun 4, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 6/4/2021. (dlb) |
| May 28, 2021 | 16 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Disclosure of Accused Products, Asserted Patents, and File Histories filed by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| May 28, 2021 | 17 | Proposed Order (15) Docket Text: PROPOSED ORDER Scheduling by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Feb 19, 2021 | 15 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1)AUROBINDOS RULE 26(a)(1) INITIAL DISCLOSURES (2)AUROBINDOS PARAGRAPH 3 DISCLOSURES filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Dec 7, 2020 | 14 | Answer to Counterclaim (12) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel) |
| Dec 2, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Steven J. Moore for Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Nov 25, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and Attorney James E. Nealon filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. Signed by Judge Leonard P. Stark on 11/25/20. (ntl) |
| Nov 24, 2020 | 13 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and Attorney James E. Nealon - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Nov 16, 2020 | 11 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Nov 16, 2020 | 12 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) |
| Nov 6, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Dov P. Grossman for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Nov 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Dov P. Grossman, Christopher J. Mandernach, Tian Huang, Kevin Hoagland-Hansen, Michael Xun Liu, and Sarahi Uribe filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 11/5/20. (ntl) |
| Nov 5, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher J. Mandernach for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Nov 4, 2020 | 10 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Dov P. Grossman, Christopher J. Mandernach, Tian Huang, Kevin Hoagland-Hansen, Michael Xun Liu, and Sarahi Uribe - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Certifications Bruce R. Genderson, Jessamyn S. Berniker, Dov P. Grossman, Christopher J. Mandernach, Tian Huang, Kevin Hoagland-Hansen, Michael Xun Liu, and Sarahi Uribe)(Silver, Daniel) |
| Nov 4, 2020 | 10 | Certifications Bruce R. Genderson, Jessamyn S. Berniker, Dov P. Grossman, Chris (8) |
| Oct 28, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Oct 28, 2020 | 9 | Summons Returned Executed (2) Docket Text: Amended SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Oct 27, 2020 | 7 | Main Document (2) Docket Text: DECLARATION of Mailing Regarding Service on Defendant Aurobindo Pharma Ltd. made on October 26, 2020 by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A & B)(Joyce, Alexandra) |
| Oct 27, 2020 | 7 | Exhibit A & B (7) |
| Oct 27, 2020 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation. Aurobindo Pharma USA, Inc. served on 10/26/2020, answer due 11/16/2020. (Joyce, Alexandra) |
| Oct 26, 2020 | 6 | Main Document (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (Attachments: # (1) Summons)(sam) |
| Oct 26, 2020 | 6 | Summons (2) |
| Oct 23, 2020 | 1 | Main Document (67) Docket Text: COMPLAINT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3287522.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: # (1) Exhibit A-C, # (2) Exhibit D-F, # (3) Exhibit G-I, # (4) Exhibit J-L, # (5) Exhibit M-O, # (6) Civil Cover Sheet)(sam) |
| Oct 23, 2020 | 1 | Exhibit A-C (283) |
| Oct 23, 2020 | 1 | Exhibit D-F (234) |
| Oct 23, 2020 | 1 | Exhibit G-I (180) |
| Oct 23, 2020 | 1 | Exhibit J-L (315) |
| Oct 23, 2020 | 1 | Exhibit M-O (237) |
| Oct 23, 2020 | 1 | Civil Cover Sheet (2) |
| Oct 23, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Oct 23, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 8, 2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 1/11/2024. (sam) |
| Oct 23, 2020 | 4 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached Reports. (Attachments: # (1) Patent/Trademark Report 2, # (2) Patent/Trademark Report 3)(sam) |
| Oct 23, 2020 | 4 | Patent/Trademark Report 2 (1) |
| Oct 23, 2020 | 4 | Patent/Trademark Report 3 (1) |
| Oct 23, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (sam) |
